C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 401/04 (2006.01) A61K 31/4155 (2006.01) A61P 35/00 (2006.01)
Patent
CA 2632283
This invention relates to polymorphs of (R)-3-[1- (2,6-Dichloro-3-fluoro-phenyl)-ethoxy]-5-(1-piperidin-4-yl- 1H-pyrazol-4-yl)-pyridin-2-ylamine represented by formula 1 that are useful in the treatment of abnormal cell growth, such as cancer, in mammals. This invention also relates to compositions including such salts and polymorphs, and to methods of using such compositions in the treatment of abnormal cell growth in mammals, especially humans. (see formula 1)
L'invention concerne des polymorphes de (R)-3-[1-(2,6-dichloro-3-fluoro-phényl)-éthoxy]-5-(1- pipéridin-4-yl-1H-pyrazol-4-yl)-pyridin-2-ylamine utiles dans le traitement d'une croissance cellulaire anormale, telle qu'un cancer, chez des mammifères. L'invention concerne également des méthodes d'utilisation de ces compositions dans le traitement d'une croissance cellulaire anormale chez des mammifères, et notamment chez l'homme.
Cui Jingrong Jean
Tran-Dube Michelle Bich
Pfizer Products Inc.
Smart & Biggar
LandOfFree
Polymorphs of a c-met/hgfr inhibitor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polymorphs of a c-met/hgfr inhibitor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polymorphs of a c-met/hgfr inhibitor will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1794849